clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Podcasts
Learning Labs
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
Molecular Dx
NHS BRCA Testing for Those with Jewish Ancestry Huge Success
News & Features
Wearable Devices Can Predict Inflammatory Bowel Disease Flare-Ups
News & Features
Xenon Gas Inhalation Shows Promise for Alzheimer’s Disease
News & Features
Researchers Identify Immune Cells That Worsen Severe Asthma
News & Features
Breast Cancer Drug Shows Promise in Treating Blood Cancers
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Podcasts
Learning Labs
Inside Precision Medicine Live
Inside Precision Medicine
Tear Drop Test Is First Rapid, Point-of-Care Diagnostic for Parkinson’s Disease
Rapid diagnostic test
Molecular Dx
Tear Drop Test Is First Rapid, Point-of-Care Diagnostic for Parkinson’s Disease
September 13, 2023
0
Coronavirus
New COVID-19 Testing Method Can Potentially Catch Infections Just Hours after Exposure
February 28, 2023
0
Coronavirus
Hong Kong Data Reveals Current COVID Vaccines Protect against Omicron, Briefly
February 15, 2023
0
Molecular Dx
Talis Wins Up-to-$8.6M from CARB-X to Develop MDx for Infectious Diseases
May 11, 2018
0
Molecular Dx
Curetis MDx Test for Lower Respiratory Tract Infection Wins FDA Clearance
April 12, 2018
0
Related Content
Targeting Cholesterol Pathways to Halt Bladder Cancer Growth
Delta Opioid Receptor Agonists Show Promise for Faster, Safer Depression Treatments
Groundbreaking Human Protein Study Launches
New AI-Based Tool Predicts Patient’s ICI Response Without Genomics
Inside Precision Medicine
![Talis Biomedical has won up to $8.6 million in CARB-X funding toward developing pathogen identification and antibiotic susceptibility molecular diagnostics for chlamydia and gonorrhea. [CDC]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/1673-768x432.jpeg "Talis Wins Up-to-$8.6M from CARB-X to Develop MDx for Infectious Diseases")
![Curetis plans to launch its Unyvero System (pictured) and Unyverso Lower Respiratory Tract Infection (LRT) Application Cartridge in the U.S. this quarter after the FDA granted the molecular diagnostic a De Novo clearance. [Curetis]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/1599-768x244.jpeg "Curetis MDx Test for Lower Respiratory Tract Infection Wins FDA Clearance")
